IBD & Intestinal Disorders
From the Journals
Recurrent Bleeding in Small-Intestinal Angiodysplasia Reduced by Thalidomide
Bleeding reductions persisting after treatment suggest that thalidomide may be disease modifying.
Short Clinical Reviews
Caring for LGBTQ+ Patients with IBD
SGM patients tend to delay or avoid seeking health care due to concern for provider mistreatment or lack of regard for their individual concerns...
From the AGA Journals
Real-world evidence: Early ileocecal resection outperforms anti-TNF therapy for Crohn’s disease
These findings add weight to previously reported data from the LIR!C trial, suggesting that ileocecal resection should be considered a first-line...
From the AGA Journals
AGA clinical practice guideline affirms role of biomarkers in Crohn’s disease management
Routine endoscopy can be avoided in asymptomatic patients with normal FCP and CRP, while in patients with severe symptoms, elevated levels of...
From the AGA Journals
Acyclcarnitines could drive IBD via dysbiosis
“These findings improve our understanding of IBD pathogenesis and disease course, and could prove valuable in biomarker research,”
Conference Coverage
Low-dose aspirin provokes no flares in patients with IBD during pregnancy
Study provides more data on the safety of aspirin use during pregnancy in patients with IBD.
From the AGA Journals
Study: CBD provides symptom relief and improvements in gastroparesis
Phase 2 trial shows promise in CBD as a treatment option for gastroparesis.
From the AGA Journals
Even a short course of opioids could jeopardize IBD patient health
The study findings amplify the safety signal from previous inpatient studies showing that even a short course of opioids may increase risks of...
Short Clinical Reviews
Advances in endoscopic therapies in inflammatory bowel disease
From mucosal resection of CAD to surgery-sparing therapies for intestinal strictures, endoscopic therapeutic options continue to grow.
Member Spotlight
Advancing personalized medicine in IBD
Joanna Melia, MD, is dedicated to advancing the field of personalized medicine for patients with IBD.